🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the immunogenicity of na...
Status
Terminated
Location
Research Site
Start Date
2014-12-01
Trial ID
NCT02142192
Treatments Being Tested
The primary objective of this study is to characterise the pharmacokinetics...
Status
Completed
Location
Research Site
Start Date
2013-12
Trial ID
NCT01978652
Treatments Being Tested
This study will compare the plasma concentration x time curve or Area Under...
Status
Terminated
Location
Christiana Care
Start Date
2020-06-16
Trial ID
NCT04183452
Treatments Being Tested
The goal of this clinical trial is to learn whether Luspatercept alone or i...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Zhejiang Chinese Medical University
Start Date
2025-05-20
Trial ID
NCT06964971
Treatments Being Tested
This study is a prospective two-arm, single blind randomized controlled tri...
Status
Recruiting
Location
Intrepid Spirit Center - Eglin Air Force Base
Start Date
2024-05-10
Trial ID
NCT05663034
The purpose of this study is to characterize the effects of 85 days treatme...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-05-20
Trial ID
NCT02410499
Treatments Being Tested
This study will evaluate the pharmacokinetics (area under the curve \[AUC\]...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT02864199
Treatments Being Tested
Primary Objective: To evaluate, in comparison with placebo, the efficacy o...
Status
Completed
Location
Investigational Site Number 8400006
Start Date
2016-12-21
Trial ID
NCT02921971
RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamid...
Status
Active Not Recruiting
Location
Regional Medical Center
Start Date
2003-11
Trial ID
NCT00070564
Treatments Being Tested
Use of PTH (1-84) a recombinant hormone in 25 µg or 50 µg doses for the tre...
Status
Completed
Location
Advance Medical Research LLC
Start Date
2011-02-09
Trial ID
NCT01268098
Treatments Being Tested